PCR76 Generating Health-State Utility Values in Patients Treated with Second-Line Systemic Therapy for Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2515
https://www.valueinhealthjournal.com/article/S1098-3015(23)05645-0/fulltext
Title :
PCR76 Generating Health-State Utility Values in Patients Treated with Second-Line Systemic Therapy for Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05645-0&doi=10.1016/j.jval.2023.09.2515
First page :
Section Title :
Open access? :
No
Section Order :
11856